{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T06:39:43Z","timestamp":1767595183375,"version":"3.48.0"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Prostate cancer (PCa) is frequently associated with poor prognosis, and immunotherapy has shown limited efficacy. This study aimed to identify novel necroptosis-related long non-coding RNAs (lncRNAs) that could predict patient outcomes and guide personalized treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Transcriptomic data from The Cancer Genome Atlas (TCGA) were analyzed using co-expression analysis and univariate Cox regression to identify lncRNAs associated with PCa progression. A necroptosis-related lncRNA prognostic model was constructed using Least Absolute Shrinkage and Selection Operator (LASSO) and validated via Kaplan-Meier survival analysis, time-dependent receiver operating characteristic (ROC) curves, Cox regression, and calibration plots. Functional analyses included Gene set enrichment analysis (GSEA), principal component analysis (PCA), immune profiling, and half-maximal inhibitory concentration (IC50) predictions to explore therapeutic implications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We established a nine-lncRNA necroptosis-related signature with strong prognostic performance. Among these, NR2F1-AS1 was identified as a core oncogenic lncRNA, showing marked upregulation in PCa tissues and promoting proliferation, invasion, and migration\n                      <jats:italic>in vitro<\/jats:italic>\n                      . The two inferred risk groups demonstrated distinct immune characteristics: hot tumors (Cluster 2) exhibited higher infiltration of activated immune cells, increased immune checkpoint expression, and greater predicted sensitivity to immunotherapy, whereas cold tumors showed immunosuppressive infiltration patterns and lower checkpoint levels. These features allowed the model to robustly distinguish cold from hot tumor phenotypes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Necroptosis-related lncRNAs, particularly NR2F1-AS1, may serve as prognostic biomarkers and inform immune-based stratification, supporting more precise personalized treatment strategies for PCa.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcell.2025.1722671","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T06:37:13Z","timestamp":1767595033000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The predictive value of necroptosis-related lncRNAs in prostate cancer prognosis and their potential to distinguish between cold and hot tumors"],"prefix":"10.3389","volume":"13","author":[{"given":"Ke","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junpeng","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunchun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JianJun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.eururo.2025.01.010","article-title":"Combination therapies in locally advanced and metastatic hormone-sensitive prostate cancer","volume":"87","author":"Azad","year":"2025","journal-title":"Eur. Urol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","article-title":"Cancer statistics in China, 2015","volume":"66","author":"Chen","year":"2016","journal-title":"CA A Cancer J. For Clin."},{"key":"B3","first-page":"1931","article-title":"Characterization of the m6A-related lncRNA signature in predicting prognosis and immune response in patients with colon cancer","volume":"26","author":"Chen","year":"2021","journal-title":"J. B.U.ON, Official J. Balkan Union Oncol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"102","DOI":"10.21037\/jgo-21-833","article-title":"Identification of lncRNAs based on different patterns of immune infiltration in gastric cancer","volume":"13","author":"Chen","year":"","journal-title":"J. Gastrointest. Oncol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"954653","DOI":"10.3389\/fimmu.2022.954653","article-title":"A novel cuproptosis-related prognostic lncRNA signature for predicting immune and drug therapy response in hepatocellular carcinoma","volume":"13","author":"Chen","year":"","journal-title":"Front. Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/tox.24177","article-title":"Deciphering m6A signatures in hepatocellular carcinoma: single-cell insights, immune landscape, and the protective role of IGFBP3","volume":"40","author":"Chen","year":"2024","journal-title":"Environ. Toxicol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1136\/gutjnl-2019-318279","article-title":"Non-coding RNAs in GI cancers: from cancer hallmarks to clinical utility","volume":"69","author":"Dragomir","year":"2020","journal-title":"Gut"},{"key":"B8","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","article-title":"Approaches to treat immune hot, altered and cold tumours with combination immunotherapies","volume":"18","author":"Galon","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"B9","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12943-019-1029-8","article-title":"The role of necroptosis in cancer biology and therapy","volume":"18","author":"Gong","year":"2019","journal-title":"Mol. Cancer"},{"key":"B10","doi-asserted-by":"publisher","first-page":"5907","DOI":"10.1111\/jcmm.14386","article-title":"Long non-coding RNA NR2F1-AS1 promoted proliferation and migration yet suppressed apoptosis of thyroid cancer cells through regulating miRNA-338-3p\/CCND1 axis","volume":"23","author":"Guo","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1756287220951404","DOI":"10.1177\/1756287220951404","article-title":"Immunotherapy in prostate cancer: current state and future perspectives","volume":"12","author":"Handa","year":"2020","journal-title":"Ther. Adv. Urology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e1884","DOI":"10.1002\/cnr2.1884","article-title":"Meta-analysis of microarray data to determine gene indicators involved in the cisplatin resistance in ovarian cancer","volume":"6","author":"Hashemi Sheikhshabani","year":"2023","journal-title":"Cancer Rep. Hob. N.J."},{"key":"B13","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1111\/jcmm.13605","article-title":"LncRNA NR2F1-AS1 regulates hepatocellular carcinoma oxaliplatin resistance by targeting ABCC1 via miR-363","volume":"22","author":"Huang","year":"2018","journal-title":"J. Cell. Mol. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41420-021-00407-1","article-title":"Progress in understanding the role of lncRNA in programmed cell death","volume":"7","author":"Jiang","year":"2021","journal-title":"Cell Death Discov."},{"key":"B15","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.ncrna.2024.01.014","article-title":"Predicting prostate cancer progression with a Multi-lncRNA expression-based risk score and nomogram integrating ISUP grading","volume":"9","author":"Ledesma-Bazan","year":"2024","journal-title":"Non-coding RNA Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.21037\/jgo-21-598","article-title":"Comprehensive bioinformatics analyses identified homeobox B9 as a potential prognostic biomarker and therapeutic target for gastric cancer","volume":"12","author":"Li","year":"","journal-title":"J. Gastrointest. Oncol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"427","DOI":"10.2147\/CMAR.S266797","article-title":"NR2F1-AS1\/miR-140\/HK2 axis regulates hypoxia-induced glycolysis and migration in hepatocellular carcinoma","volume":"13","author":"Li","year":"","journal-title":"Cancer Manag. Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"6570879","DOI":"10.1155\/2022\/6570879","article-title":"IPO5 mediates EMT and promotes esophageal cancer development through the RAS-ERK pathway","volume":"2022","author":"Li","year":"2022","journal-title":"Oxidative Med. Cell. Longev."},{"key":"B19","doi-asserted-by":"publisher","first-page":"3881932","DOI":"10.1155\/2021\/3881932","article-title":"The effect and mechanism of lncRNA NR2F1-As1\/miR-493-5p\/MAP3K2 axis in the progression of gastric cancer","volume":"2021","author":"Liao","year":"2021","journal-title":"J. Oncol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"736980","DOI":"10.3389\/fcell.2021.736980","article-title":"NR2F1-AS1 promotes pancreatic ductal adenocarcinoma progression through competing endogenous RNA regulatory network constructed by sponging miRNA-146a-5p\/miRNA-877-5p","volume":"9","author":"Luo","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"688949","DOI":"10.3389\/fcell.2021.688949","article-title":"NR2F1-AS1\/miR-190a\/PHLDB2 induces the epithelial-mesenchymal transformation process in gastric cancer by promoting phosphorylation of AKT3","volume":"9","author":"Lv","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s11934-024-01217-5","article-title":"Overview of radiation therapy in the management of localized and metastatic prostate cancer","volume":"25","author":"Mattes","year":"2024","journal-title":"Curr. Urology Reports"},{"key":"B23","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12885-023-11778-2","article-title":"Establishment of a prognostic risk prediction model incorporating disulfidptosis-related lncRNA for patients with prostate cancer","volume":"24","author":"Mulati","year":"2024","journal-title":"BMC Cancer"},{"key":"B24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nrg.2015.10","article-title":"Unique features of long non-coding RNA biogenesis and function","volume":"17","author":"Quinn","year":"2016","journal-title":"Nat. Rev. Genet."},{"key":"B25","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1158\/1078-0432.ccr-0155-3","article-title":"Identification of necrosis-associated genes in glioblastoma by cDNA microarray analysis","volume":"10","author":"Raza","year":"2004","journal-title":"Clin. Cancer Res. An Official J. Am. Assoc. For Cancer Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.euo.2022.03.001","article-title":"Establishing a foundation for studying the immune contexture across the spectrum of bladder cancer","volume":"5","author":"Roberts","year":"2022","journal-title":"Eur. Urol. Oncol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1002\/1878-0261.12704","article-title":"Long non-coding NR2F1-AS1 is associated with tumor recurrence in estrogen receptor-positive breast cancers","volume":"14","author":"Sanchez Calle","year":"2020","journal-title":"Mol. Oncol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1080\/17512433.2021.1949287","article-title":"Targeting the spectrum of immune checkpoints in prostate cancer","volume":"14","author":"Sena","year":"2021","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.3390\/brainsci13071051","article-title":"A nomogram for predicting the recurrence of acute non-cardioembolic ischemic stroke: a retrospective hospital-based cohort analysis","volume":"13","author":"Shao","year":"2023","journal-title":"Brain Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"eaaw2004","DOI":"10.1126\/sciimmunol.aaw2004","article-title":"Intratumoral activation of the necroptotic pathway components RIPK1 and RIPK3 potentiates antitumor immunity","volume":"4","author":"Snyder","year":"2019","journal-title":"Sci. Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e002919","DOI":"10.1136\/jitc-2021-002919","article-title":"Combined CTLA-4 and PD-L1 blockade in patients with chemotherapy-na\u00efve metastatic castration-resistant prostate cancer is associated with increased myeloid and neutrophil immune subsets in the bone microenvironment","volume":"9","author":"Subudhi","year":"2021","journal-title":"J. For Immunother. Cancer"},{"key":"B32","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer J. For Clin."},{"key":"B33","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13045-020-00946-7","article-title":"Ferroptosis, necroptosis, and pyroptosis in anticancer immunity","volume":"13","author":"Tang","year":"2020","journal-title":"J. Hematol. and Oncol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ydbio.2018.09.011","article-title":"A spontaneous mouse deletion in Mctp1 uncovers a long-range cis-regulatory region crucial for NR2F1 function during inner ear development","volume":"443","author":"Tarchini","year":"2018","journal-title":"Dev. Biol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s00345-020-03497-1","article-title":"Immunotherapy in prostate cancer: new horizon of hurdles and hopes","volume":"39","author":"Tsaur","year":"2021","journal-title":"World J. Urology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1089\/cbr.2019.3237","article-title":"LncRNA NR2F1-AS1 regulates miR-371a-3p\/TOB1 axis to suppress proliferation of colorectal cancer cells","volume":"35","author":"Wang","year":"2020","journal-title":"Cancer Biotherapy and Radiopharm."},{"key":"B37","doi-asserted-by":"publisher","first-page":"275","DOI":"10.7150\/jca.89338","article-title":"Interplay of sphingolipid metabolism in predicting prognosis of GBM patients: towards precision immunotherapy","volume":"15","author":"Wang","year":"2024","journal-title":"J. Cancer"},{"key":"B38","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12943-020-01185-7","article-title":"Noncoding RNAs in gastric cancer: implications for drug resistance","volume":"19","author":"Wei","year":"2020","journal-title":"Mol. Cancer"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1002\/jcb.29435","article-title":"NR2F1-AS1 regulated miR-423-5p\/SOX12 to promote proliferation and invasion of papillary thyroid carcinoma","volume":"121","author":"Yang","year":"2020","journal-title":"J. Cell. Biochem."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1093\/ije\/dyx034","article-title":"MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data","volume":"46","author":"Yavorska","year":"2017","journal-title":"Int. J. Epidemiol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12943-020-01219-0","article-title":"Long non-coding RNAs towards precision medicine in gastric cancer: early diagnosis, treatment, and drug resistance","volume":"19","author":"Yuan","year":"2020","journal-title":"Mol. Cancer"},{"key":"B42","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.bbrc.2019.09.015","article-title":"NR2F1-induced NR2F1-AS1 promotes esophageal squamous cell carcinoma progression via activating hedgehog signaling pathway","volume":"519","author":"Zhang","year":"2019","journal-title":"Biochem. Biophysical Res. Commun."},{"key":"B43","doi-asserted-by":"publisher","first-page":"7660","DOI":"10.18632\/aging.103564","article-title":"Long noncoding RNA NR2F1-AS1 promotes the malignancy of non-small cell lung cancer via sponging microRNA-493-5p and thereby increasing ITGB1 expression","volume":"13","author":"Zhang","year":"2020","journal-title":"Aging"},{"key":"B44","doi-asserted-by":"publisher","first-page":"8236","DOI":"10.1111\/jcmm.15499","article-title":"lncRNA NR2F1-AS1 promotes breast cancer angiogenesis through activating IGF-1\/IGF-1R\/ERK pathway","volume":"24","author":"Zhang","year":"2020","journal-title":"J. Cell. Mol. Med."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2025.1722671\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T06:37:14Z","timestamp":1767595034000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2025.1722671\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":44,"alternative-id":["10.3389\/fcell.2025.1722671"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2025.1722671","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"article-number":"1722671"}}